PLoS Pathogens (Nov 2018)

Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells.

  • Justine Schaeffer,
  • Xavier Carnec,
  • Stéphanie Reynard,
  • Mathieu Mateo,
  • Caroline Picard,
  • Natalia Pietrosemoli,
  • Marie-Agnès Dillies,
  • Sylvain Baize

DOI
https://doi.org/10.1371/journal.ppat.1007430
Journal volume & issue
Vol. 14, no. 11
p. e1007430

Abstract

Read online

Lassa virus (LASV) is responsible for a viral hemorrhagic fever in humans and the death of 3,000 to 5,000 people every year. The immune response to LASV is poorly understood, but type I interferon (IFN-I) and T-cell responses appear to be critical for the host. We studied the response of myeloid dendritic cells (mDC) to LASV, as mDCs are involved in both IFN-I production and T-cell activation. We compared the response of primary human mDCs to LASV and Mopeia virus (MOPV), which is similar to LASV, but non-pathogenic. We showed that mDCs produced substantial amounts of IFN-I in response to both LASV and MOPV. However, only MOPV-infected mDCs were able to activate T cells. More surprisingly, coculture with T cells completely inhibited the activation of LASV-infected mDCs. These differences between LASV and MOPV were mostly due to the LASV nucleoprotein, which has major immunosuppressive properties, but the glycoprotein was also involved. Overall, these results suggest that mDCs may be important for the global response to LASV and play a role in the outcome of Lassa fever.